Please enable JavaScript to continue using this application.

Compare $ANVS vs $CELU | Chartloom

Compare

$ANVS vs $CELU

Annovis Bio Inc · Celularity Inc

ANVS

Annovis Bio Inc

CELU

Celularity Inc

Compare $ANVS vs $CELU

Comparing Annovis Bio Inc and Celularity Inc

ANVSAnnovis Bio Inc

CELUCelularity Inc

ANVSAnnovis Bio Inc

Market cap

$42M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.8%

52W performance

-46.7%

FCF yield

-103.4%

CELUCelularity Inc

Market cap

$45M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.0%

YTD performance

28.9%

52W performance

-27.4%

FCF yield

-29.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANVS

CELU

Detailed metrics comparison

ANVS

Annovis Bio Inc

CELU

Celularity Inc

Market Cap

ANVS$42M

CELU$45M

Enterprise Value

ANVS$23M

CELU$87M

Price

ANVS$1.21

CELU$1.56

P/E Ratio

ANVSN/A

CELUN/A

P/S Ratio

ANVS0.00x

CELU1.70x

EV/Sales

ANVS0.00x

CELU3.27x

EV/EBITDA

ANVS0.00x

CELU0.00x

P/B Ratio

ANVS16.11x

CELU5.88x

P/FCF Ratio

ANVSN/A

CELUN/A

EV/FCF

ANVS-0.54x

CELU-6.55x

PEG Ratio

ANVSN/A

CELUN/A

Forward P/E (NTM)

ANVSN/A

CELUN/A

Forward P/S (NTM)

ANVSN/A

CELUN/A

Revenue (TTM)

ANVS$0

CELU$27M

Revenue Growth (YoY)

ANVSN/A

CELU-51.0%

Forward Rev Growth

ANVS507.4%

CELU0.0%

Gross Margin (TTM)

ANVS0.0%

CELU24.4%

Operating Margin (TTM)

ANVS0.0%

CELU0.0%

EBITDA Margin (TTM)

ANVS0.0%

CELU-203.4%

Net Margin (TTM)

ANVS0.0%

CELU-346.0%

FCF Margin (TTM)

ANVSN/A

CELU-49.9%

Net Income (TTM)

ANVS$-50M

CELU$-92M

FCF (TTM)

ANVS$-43M

CELU$-13M

EPS (TTM)

ANVS-$1.32

CELU-$3.23

ROE (TTM)

ANVS-31808.0%

CELU-27244.0%

ROA (TTM)

ANVS-25878.0%

CELU-7794.0%

ROIC (TTM)

ANVS-31808.0%

CELU-9204.0%

Cash

ANVS$19M

CELU$6M

Debt

ANVS$0

CELU$48M

Net Cash/Debt

ANVS$19M

CELU$-42M

Current Ratio (TTM)

ANVS3.47x

CELU0.15x

Quick Ratio (TTM)

ANVS2.95x

CELU0.14x

Debt/Equity (TTM)

ANVS0.00x

CELU4.79x

Debt/Assets (TTM)

ANVS0.0%

CELU0.0%

Interest Coverage (TTM)

ANVSN/A

CELUN/A

Net Debt/EBITDA (TTM)

ANVS0.00x

CELU0.00x

Beta

ANVS1.32

CELU0.88

52W Performance

ANVS-46.7%

CELU-27.4%

YTD Performance

ANVS-66.8%

CELU28.9%

% from 52W High

ANVS-78.0%

CELU-38.8%

% from 52W Low

ANVS16.3%

CELU178.5%

Asset Turnover (TTM)

ANVS0.00x

CELU0.23x

FCF Yield (TTM)

ANVS-103.4%

CELU-29.3%

Earnings Yield (TTM)

ANVS-118.1%

CELU-203.4%

Dividend Yield (TTM)

ANVSN/A

CELUN/A

Rule of 40

ANVS0.0

CELU-101.0

EV/GP/RG

ANVSN/A

CELUN/A

Ticker research

View ANVS research View CELU research

Metric	ANVS Annovis Bio Inc	CELU Celularity Inc
Market & Valuation
Market Cap	$42M	$45M
Enterprise Value	$23M	$87M
Price	$1.21	$1.56
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.70x
EV/Sales	0.00x	3.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	5.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	-6.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$27M
Revenue Growth (YoY)	N/A	-51.0%
Forward Rev Growth	507.4%	0.0%
Profitability
Gross Margin (TTM)	0.0%	24.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-203.4%
Net Margin (TTM)	0.0%	-346.0%
FCF Margin (TTM)	N/A	-49.9%
Net Income (TTM)	$-50M	$-92M
FCF (TTM)	$-43M	$-13M
EPS (TTM)	-$1.32	-$3.23
ROE (TTM)	-31808.0%	-27244.0%
ROA (TTM)	-25878.0%	-7794.0%
ROIC (TTM)	-31808.0%	-9204.0%
Financial Health
Cash	$19M	$6M
Debt	$0	$48M
Net Cash/Debt	$19M	$-42M
Current Ratio (TTM)	3.47x	0.15x
Quick Ratio (TTM)	2.95x	0.14x
Debt/Equity (TTM)	0.00x	4.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.88
52W Performance	-46.7%	-27.4%
YTD Performance	-66.8%	28.9%
% from 52W High	-78.0%	-38.8%
% from 52W Low	16.3%	178.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.23x
FCF Yield (TTM)	-103.4%	-29.3%
Earnings Yield (TTM)	-118.1%	-203.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-101.0
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View CELU research

Valuation

P/S Ratio

ANVS

0.00x

CELU

1.70x

EV/FCF

CELU

-6.55x

ANVS

-0.54x

Growth & revenue

Revenue Growth TTM

CELU

-51.0%

Forward Revenue Growth

ANVS

507.4%

CELU

0.0%

Profitability & performance

Gross Margin

CELU

24.4%

ANVS

0.0%

ROE

CELU

-27244.0%

ANVS

-31808.0%

FCF Yield %

CELU

-29.3%

ANVS

-103.4%

52-Week Performance

CELU

-27.4%

ANVS

-46.7%

Detailed metrics comparison

ANVS

Annovis Bio Inc

CELU

Celularity Inc

Market Cap

ANVS$42M

CELU$45M

Enterprise Value

ANVS$23M

CELU$87M

Price

ANVS$1.21

CELU$1.56

P/E Ratio

ANVSN/A

CELUN/A

P/S Ratio

ANVS0.00x

CELU1.70x

EV/Sales

ANVS0.00x

CELU3.27x

EV/EBITDA

ANVS0.00x

CELU0.00x

P/B Ratio

ANVS16.11x

CELU5.88x

P/FCF Ratio

ANVSN/A

CELUN/A

EV/FCF

ANVS-0.54x

CELU-6.55x

PEG Ratio

ANVSN/A

CELUN/A

Forward P/E (NTM)

ANVSN/A

CELUN/A

Forward P/S (NTM)

ANVSN/A

CELUN/A

Revenue (TTM)

ANVS$0

CELU$27M

Revenue Growth (YoY)

ANVSN/A

CELU-51.0%

Forward Rev Growth

ANVS507.4%

CELU0.0%

Gross Margin (TTM)

ANVS0.0%

CELU24.4%

Operating Margin (TTM)

ANVS0.0%

CELU0.0%

EBITDA Margin (TTM)

ANVS0.0%

CELU-203.4%

Net Margin (TTM)

ANVS0.0%

CELU-346.0%

FCF Margin (TTM)

ANVSN/A

CELU-49.9%

Net Income (TTM)

ANVS$-50M

CELU$-92M

FCF (TTM)

ANVS$-43M

CELU$-13M

EPS (TTM)

ANVS-$1.32

CELU-$3.23

ROE (TTM)

ANVS-31808.0%

CELU-27244.0%

ROA (TTM)

ANVS-25878.0%

CELU-7794.0%

ROIC (TTM)

ANVS-31808.0%

CELU-9204.0%

Cash

ANVS$19M

CELU$6M

Debt

ANVS$0

CELU$48M

Net Cash/Debt

ANVS$19M

CELU$-42M

Current Ratio (TTM)

ANVS3.47x

CELU0.15x

Quick Ratio (TTM)

ANVS2.95x

CELU0.14x

Debt/Equity (TTM)

ANVS0.00x

CELU4.79x

Debt/Assets (TTM)

ANVS0.0%

CELU0.0%

Interest Coverage (TTM)

ANVSN/A

CELUN/A

Net Debt/EBITDA (TTM)

ANVS0.00x

CELU0.00x

Beta

ANVS1.32

CELU0.88

52W Performance

ANVS-46.7%

CELU-27.4%

YTD Performance

ANVS-66.8%

CELU28.9%

% from 52W High

ANVS-78.0%

CELU-38.8%

% from 52W Low

ANVS16.3%

CELU178.5%

Asset Turnover (TTM)

ANVS0.00x

CELU0.23x

FCF Yield (TTM)

ANVS-103.4%

CELU-29.3%

Earnings Yield (TTM)

ANVS-118.1%

CELU-203.4%

Dividend Yield (TTM)

ANVSN/A

CELUN/A

Rule of 40

ANVS0.0

CELU-101.0

EV/GP/RG

ANVSN/A

CELUN/A

Ticker research

View ANVS research View CELU research

Metric	ANVS Annovis Bio Inc	CELU Celularity Inc
Market & Valuation
Market Cap	$42M	$45M
Enterprise Value	$23M	$87M
Price	$1.21	$1.56
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.70x
EV/Sales	0.00x	3.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	5.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	-6.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$27M
Revenue Growth (YoY)	N/A	-51.0%
Forward Rev Growth	507.4%	0.0%
Profitability
Gross Margin (TTM)	0.0%	24.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-203.4%
Net Margin (TTM)	0.0%	-346.0%
FCF Margin (TTM)	N/A	-49.9%
Net Income (TTM)	$-50M	$-92M
FCF (TTM)	$-43M	$-13M
EPS (TTM)	-$1.32	-$3.23
ROE (TTM)	-31808.0%	-27244.0%
ROA (TTM)	-25878.0%	-7794.0%
ROIC (TTM)	-31808.0%	-9204.0%
Financial Health
Cash	$19M	$6M
Debt	$0	$48M
Net Cash/Debt	$19M	$-42M
Current Ratio (TTM)	3.47x	0.15x
Quick Ratio (TTM)	2.95x	0.14x
Debt/Equity (TTM)	0.00x	4.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.88
52W Performance	-46.7%	-27.4%
YTD Performance	-66.8%	28.9%
% from 52W High	-78.0%	-38.8%
% from 52W Low	16.3%	178.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.23x
FCF Yield (TTM)	-103.4%	-29.3%
Earnings Yield (TTM)	-118.1%	-203.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-101.0
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View CELU research